Sathees C Raghavan
Overview
Explore the profile of Sathees C Raghavan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
2493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumari N, Kaur E, Raghavan S, Sengupta S
Curr Opin Pharmacol
. 2024 Dec;
80:102496.
PMID: 39724838
DNA damage signaling is a highly coordinated cellular process which is required for the removal of DNA lesions. Amongst the different types of DNA damage, double-strand breaks (DSBs) are the...
2.
Roy U, Sharma A, Sharma S, Dahal S, Kumari N, Desai S, et al.
Mol Cell Biol
. 2024 Nov;
44(12):590-606.
PMID: 39511874
One of the primary reasons behind the pathogenesis of T cell acute lymphoblastic leukemia (T-ALL) is the deregulation of the transcription factor . The exon 4 of harbors several driver...
3.
Roy U, Desai S, Kumari S, Bushra T, Choudhary B, Raghavan S
J Immunol
. 2024 Sep;
213(8):1125-1138.
PMID: 39269689
The process of Ag receptor diversity is initiated by RAGs consisting of RAG1 and RAG2 in developing lymphocytes. Besides its role as a sequence-specific nuclease during V(D)J recombination, RAGs can...
4.
Manjunath M, Ravindran F, Sharma S, Siddiqua H, Raghavan S, Choudhary B
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928195
Targeted cancer therapy aims to disrupt the functions of proteins that regulate cancer progression, mainly by using small molecule inhibitors (SMIs). SMIs exert their effect by modulating signalling pathways, organelle...
5.
Gopalakrishnan V, Roy U, Srivastava S, Kariya K, Sharma S, Javedakar S, et al.
Cell Mol Life Sci
. 2024 Jan;
81(1):21.
PMID: 38196006
BCL6 translocation is one of the most common chromosomal translocations in cancer and results in its enhanced expression in germinal center B cells. It involves the fusion of BCL6 with...
6.
Prabhu D, Ray U, Rajeev A, Joy R, George A, George J, et al.
ACS Omega
. 2023 Dec;
8(49):47315.
PMID: 38107917
[This corrects the article DOI: 10.1021/acsomega.3c05816.].
7.
Kumari R, Roy U, Desai S, Mondal A, Nair R, Nilavar N, et al.
Biochem J
. 2023 Dec;
480(24):2061-2077.
PMID: 38084601
The stringent regulation of RAGs (Recombination activating genes), the site-specific endonuclease responsible for V(D)J recombination, is important to prevent genomic rearrangements and chromosomal translocations in lymphoid cells. In the present...
8.
Joy R, Siddiqua H, Sharma S, Raveendran M, John F, Hassan P, et al.
ACS Omega
. 2023 Nov;
8(43):40729-40740.
PMID: 37929147
A chemical inhibitor of antiapoptotic protein, BCL2, known as Disarib, suffers poor solubility in aqueous environments; thereby limiting its potential as a chemotherapeutic agent. To overcome this limitation and enhance...
9.
Kumari N, Das K, Sharma S, Dahal S, Desai S, Roy U, et al.
J Biol Chem
. 2023 Nov;
299(12):105431.
PMID: 37926284
t(8;14) translocation is the hallmark of Burkitt's lymphoma and results in c-MYC deregulation. During the translocation, c-MYC gene on chromosome 8 gets juxtaposed to the Ig switch regions on chromosome...
10.
Kumari N, Antil H, Kumari S, Raghavan S
Genomics
. 2023 Oct;
115(6):110731.
PMID: 37871849
Ligase IV is a key enzyme involved during DNA double-strand breaks (DSBs) repair through nonhomologous end joining (NHEJ). However, in contrast to Ligase IV deficient mouse cells, which are embryonic...